These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10954004)

  • 21. A randomized prospective double-blind placebo-controlled study of gallopamil, calcium antagonist of the verapamil type, in stable cyclosporine-treated renal transplant recipients.
    Gossmann J; Mondorf U; Dietz A; Kramer W; Kachel HG; Geiger H; Scheuermann EH
    Transplant Proc; 2002 Aug; 34(5):1767-70. PubMed ID: 12176568
    [No Abstract]   [Full Text] [Related]  

  • 22. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion.
    Ruggenenti P; Perico N; Mosconi L; Gaspari F; Benigni A; Amuchastegui CS; Bruzzi I; Remuzzi G
    Kidney Int; 1993 Mar; 43(3):706-11. PubMed ID: 8455370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of benidipine hydrochloride, a long-acting T-type calcium channel blocker, on blood pressure and renal function in hypertensive patients with diabetes mellitus. Analysis after switching from cilnidipine to benidipine.
    Seino H; Miyaguchi S; Yamazaki T; Ota S; Yabe R; Suzuki S
    Arzneimittelforschung; 2007; 57(8):526-31. PubMed ID: 17915639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do calcium channel blockers have renal protective effects?
    Reams GP
    Drugs Aging; 1994 Oct; 5(4):263-87. PubMed ID: 7827397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of cyclosporin A and amlodipine: blood cyclosporin A levels, hypertension and kidney function.
    Schrama YC; Koomans HA
    J Hypertens Suppl; 1998 Sep; 16(4):S33-8. PubMed ID: 9817190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of efonidipine and ACE inhibitors on proteinuria in human hypertension with renal impairment.
    Hayashi K; Kumagai H; Saruta T
    Am J Hypertens; 2003 Feb; 16(2):116-22. PubMed ID: 12559677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of calcium antagonist subclasses on markers of nephropathy progression.
    Bakris GL; Weir MR; Secic M; Campbell B; Weis-McNulty A
    Kidney Int; 2004 Jun; 65(6):1991-2002. PubMed ID: 15149313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart rate in hypertensive patients treated with ACE inhibitors and long-acting dihydropyridine calcium antagonists.
    Pierdomenico SD; Bucci A; Lapenna D; Cuccurullo F; Mezzetti A
    J Cardiovasc Pharmacol; 2002 Aug; 40(2):288-95. PubMed ID: 12131558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies.
    Pedersen EB; Madsen JK; Sørensen SS; Zachariae H
    Kidney Int Suppl; 1996 Jun; 55():S94-6. PubMed ID: 8743522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS.
    Leoncini G; Martinoli C; Viazzi F; Ravera M; Parodi D; Ratto E; Vettoretti S; Tomolillo C; Derchi LE; Deferrari G; Pontremoli R
    Nephron; 2002 Feb; 90(2):169-73. PubMed ID: 11818701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal effects of 1,4-dihydropyridines in animal models of hypertension and renal failure.
    Garthoff B; Hirth C; Federmann A; Kazda S; Stasch JP
    J Cardiovasc Pharmacol; 1987; 9 Suppl 1():S8-13. PubMed ID: 2441191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between the antiproteinuric effects of the calcium channel blockers benidipine and cilnidipine in combination with angiotensin receptor blockers in hypertensive patients with chronic kidney disease.
    Abe M; Okada K; Maruyama N; Matsumoto S; Maruyama T; Fujita T; Matsumoto K; Soma M
    Expert Opin Investig Drugs; 2010 Sep; 19(9):1027-37. PubMed ID: 20649501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of nifedipine on renal allograft function and survival beyond one year.
    Shin GT; Cheigh JS; Riggio RR; Suthanthiran M; Stubenbord WT; Serur D; Wang JC; Rubin AL; Stenzel KH
    Clin Nephrol; 1997 Jan; 47(1):33-6. PubMed ID: 9021239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial.
    Halimi JM; Giraudeau B; Buchler M; Al-Najjar A; Etienne I; Laouad I; Bruyère F; Lebranchu Y
    Clin Transplant; 2007; 21(2):277-84. PubMed ID: 17425758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease.
    Marin R; Ruilope LM; Aljama P; Aranda P; Segura J; Diez J;
    J Hypertens; 2001 Oct; 19(10):1871-6. PubMed ID: 11593109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal effects of amlodipine in normotensive renal transplant recipients.
    Venkat Raman G; Feehally J; Coates RA; Elliott HL; Griffin PJ; Olubodun JO; Wilkinson R
    Nephrol Dial Transplant; 1999 Feb; 14(2):384-8. PubMed ID: 10069193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of dihydropyridine calcium antagonists in hypertensive patients with impaired renal function.
    Hansson LH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S36-9; discussion S59-62. PubMed ID: 2483570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of calcium antagonists on blood pressure and responses to alpha-adrenoceptor agonists in hypertensive rabbits.
    Hamilton CA; Jardine E; Sumner DJ; Reid JL
    Clin Exp Pharmacol Physiol; 1987 Feb; 14(2):77-85. PubMed ID: 2886240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of calcium channel blockers in diabetic renal transplant patients: preliminary observations on protection from sepsis.
    Weinrauch LA; D'Elia JA; Gleason RE; Shaffer D; Monaco AP
    Clin Nephrol; 1995 Sep; 44(3):185-92. PubMed ID: 8556835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.